Mirum Pharmaceuticals, Inc. (MIRM)

Mirum Pharmaceuticals Revenue

Mirum Pharmaceuticals had revenue of $127.79M in the quarter ending June 30, 2025, with 64.09% growth. This brings the company's revenue in the last twelve months to $429.16M, up 62.33% year-over-year. In the year 2024, Mirum Pharmaceuticals had annual revenue of $336.89M with 80.76% growth.

• Revenue (ttm): $429.16M
• Revenue Growth: +62.33%
• P/S Ratio: 8.42
• Revenue / Employee: $1,332,798
• Employees: 322
• Market Cap: 3.73B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	336.89M	150.51M	80.76%
Dec 31, 2023	186.37M	109.31M	141.85%
Dec 31, 2022	77.06M	57.92M	302.66%
Dec 31, 2021	19.14M	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.